Streamlined surgical approach for coexistent urethral stricture and benign prostatic enlargement: feasibility, safety and patency results.
HoLEP
LUTS
Prostatic hyperplasia
Transurethral resection of prostate
Urethral stricture
Urethroplasty
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
25 Oct 2024
25 Oct 2024
Historique:
received:
18
08
2024
accepted:
01
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
To evaluate the technical feasibility, safety, and patency results of a simultaneous surgical approach to repair urethral stricture and treat benign prostatic enlargement endoscopically in a highly selected group of patients at a tertiary referral center. We hypothesize that this is technically feasible, safe, and does not affect urethroplasty outcomes. A retrospective review of adult men who underwent simultaneous urethroplasty and endoscopic prostatic surgery between May 2017 and May 2024 at our institution was conducted. Patients with strictures < 15 French and prostates with adverse prognostic features of response to medical treatment were included. The primary outcome was technical feasibility and safety. The secondary outcome was stricture-free survival. Twenty men were treated during the study period. The median length of the urethral stricture was 3.0 cm (IQR 2.0-5.0), and the median size of the prostate was 95.0 cc (IQR 63.3-128.3). All patients were treated successfully with a median operative time of 194.5 min (IQR 180.0-246.8), and no procedures required conversion to a staged procedure or open prostatectomy. There were seven Clavien-Dindo I-II complications and one Clavien-Dindo IIIb complication (hematuria requiring endoscopic clot evacuation). At 22 months follow-up, two cases of urethral re-stricture were diagnosed, with one case requiring redo urethroplasty, though none had previous major complications. The combination of urethroplasty and endoscopic surgery for benign prostatic enlargement at the same stage appears to be technically viable and safe, and it does not compromise medium-term urethral patency results in a carefully selected group of patients.
Identifiants
pubmed: 39455449
doi: 10.1007/s00345-024-05306-5
pii: 10.1007/s00345-024-05306-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
594Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 43:289–297. https://doi.org/10.1016/j.ucl.2016.04.001
doi: 10.1016/j.ucl.2016.04.001
pubmed: 27476122
Liu H, Tian Y, Luo G et al (2021) Modified bladder outlet obstruction index for powerful efficacy prediction of transurethral resection of prostate with benign prostatic hyperplasia. BMC Urol 21:170. https://doi.org/10.1186/s12894-021-00937-x
doi: 10.1186/s12894-021-00937-x
pubmed: 34872539
pmcid: 8650302
Ntia IO, Dikko AA (2002) The pattern of association of urethral stricture with benign prostatic hyperplasia in Nigerians. Sahel Med J 5:190–194. https://doi.org/10.4314/smj2.v5i4.12827
doi: 10.4314/smj2.v5i4.12827
Chapman DW, Bekkema J, Rourke K (2021) Urinary symptom nonresponse (“LUTS Failure”) after urethroplasty: incidence and associations. J Urol 206:986–993. https://doi.org/10.1097/JU.0000000000001840
doi: 10.1097/JU.0000000000001840
pubmed: 34032496
Benign prostatic hyperplasia (BPH) guideline—American urological association. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline . Accessed 20 May 2024
Management of non-neurogenic male LUTS. In: Uroweb—European Association of Urology. https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts . Accessed 20 May 2024
Launer BM, McVary KT, Ricke WA, Lloyd GL (2021) The rising worldwide impact of benign prostatic hyperplasia. BJU Int 127:722–728. https://doi.org/10.1111/bju.15286
doi: 10.1111/bju.15286
pubmed: 33124118
Chung ASJ, McCammon KA (2017) Incidence and management of lower urinary tract symptoms after urethral stricture repair. Curr Urol Rep 18:70. https://doi.org/10.1007/s11934-017-0716-5
doi: 10.1007/s11934-017-0716-5
pubmed: 28718163
Horiguchi A, Shinchi M, Masunaga A et al (2018) Do transurethral treatments increase the complexity of urethral strictures? J Urol. https://doi.org/10.1016/j.juro.2017.08.100
doi: 10.1016/j.juro.2017.08.100
pubmed: 28866464
Figueiredo FCA, Teloken PE (2022) Minimally invasive laser enucleation of the prostate (MiLEP): Slim (22Ch) and Ultra Slim (18.5Ch) HoLEP. Urol Video J 14:100146. https://doi.org/10.1016/j.urolvj.2022.100146
doi: 10.1016/j.urolvj.2022.100146
Baradaran N, Fergus KB, Moses RA et al (2019) Clinical significance of cystoscopic urethral stricture recurrence after anterior urethroplasty: a multi-institution analysis from Trauma and Urologic Reconstructive Network of Surgeons (TURNS). World J Urol 37:2763–2768. https://doi.org/10.1007/s00345-019-02653-6
doi: 10.1007/s00345-019-02653-6
pubmed: 30712091
Dornbier RA, Kirshenbaum EJ, Nelson MH et al (2019) Socioeconomic and patient-related factors for the management of male urethral stricture disease. World J Urol 37:2523–2531. https://doi.org/10.1007/s00345-019-02702-0
doi: 10.1007/s00345-019-02702-0
pubmed: 30810835
Payne SR, Chalwe M (2022) Understanding the needs of low-income countries: how urologists can help. BJU Int 129:9–16. https://doi.org/10.1111/bju.15628
doi: 10.1111/bju.15628
pubmed: 34738315
Patel A, Nunez R, Mmeje CO, Humphreys MR (2014) Safety and feasibility of concomitant surgery during holmium laser enucleation of the prostate (HoLEP). World J Urol 32:1543–1549. https://doi.org/10.1007/s00345-014-1254-0
doi: 10.1007/s00345-014-1254-0
pubmed: 24500193
Garabed LR, Wang S, Meskawi M et al (2024) Complex buccal graft urethroplasty combined with holep in the setting of concomitant urethral stricture disease and severe benign prostatic hyperplasia: a case report. JU Open Plus 2:e00043. https://doi.org/10.1097/JU9.0000000000000139
doi: 10.1097/JU9.0000000000000139
Urethral strictures. In: Uroweb—European Association of Urology. https://uroweb.org/guidelines/urethral-strictures/chapter/classifications . Accessed 17 Sept 2024
Tobia IP, Gil SA, Nanni FD et al (2022) Simplified urethral score system for predicting complex anterior urethroplasty. Actas Urol Esp. https://doi.org/10.1016/j.acuroe.2021.12.002
doi: 10.1016/j.acuroe.2021.12.002
pubmed: 35260371
Warner JN, Malkawi I, Dhradkeh M et al (2015) A multi-institutional evaluation of the management and outcomes of long-segment urethral strictures. Urology 85:1483–1487. https://doi.org/10.1016/j.urology.2015.01.041
doi: 10.1016/j.urology.2015.01.041
pubmed: 25868738
Favre GA, Villa SG, Scherñuk J et al (2021) Glans preservation in surgical treatment of distal urethral strictures with dorsal buccal mucosa graft onlay by subcoronal approach. Urology 152:148–152. https://doi.org/10.1016/j.urology.2020.12.014
doi: 10.1016/j.urology.2020.12.014
pubmed: 33359490
Das AK, Teplitsky S, Humphreys MR (2019) Holmium laser enucleation of the prostate (HoLEP): a review and update. Can J Urol 26:13–19
pubmed: 31481144
Lee MS, Assmus MA, Ganesh M et al (2023) An outcomes comparison between holmium laser enucleation of the prostate, open simple prostatectomy, and robotic simple prostatectomy for large gland benign prostatic hypertrophy. Urology 173:180–186. https://doi.org/10.1016/j.urology.2022.12.018
doi: 10.1016/j.urology.2022.12.018
pubmed: 36586427
Di Maida F, Grosso AA, Tellini R et al (2023) Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burden. Int Braz J Urol 49:341–350. https://doi.org/10.1590/S1677-5538.IBJU.2022.0174
doi: 10.1590/S1677-5538.IBJU.2022.0174
pubmed: 36794848
pmcid: 10335890
Al-Qudah HS, Santucci RA (2005) Extended complications of urethroplasty. Int Braz J Urol 31:315–323. https://doi.org/10.1590/s1677-55382005000400004
doi: 10.1590/s1677-55382005000400004
pubmed: 16137399
Krambeck A, Agarwal D, Lingeman J et al (2020) Temporary perineal urethrostomy during holmium laser enucleation of the prostate (HoLEP). Science Repository OU
Melchior J, Valk WL, Foret JD, Mebust WK (1974) Transurethral resection of the prostate via perineal urethrostomy: complete analysis of 7 years of experience. J Urol 111:640–643. https://doi.org/10.1016/s0022-5347(17)60035-1
doi: 10.1016/s0022-5347(17)60035-1
pubmed: 4823972
Bissada NK (1977) Transurethral resection of prostate via perineal urethrostomy: follow-up report. Urology 10:39–41. https://doi.org/10.1016/0090-4295(77)90036-x
doi: 10.1016/0090-4295(77)90036-x
pubmed: 878122
Porto JG, Blachman-Braun R, Delgado C et al (2023) Is holmium laser enucleation of the prostate truly size-independent? A critical evaluation at the extreme ends of the spectrum. Urology 182:204–210. https://doi.org/10.1016/j.urology.2023.09.002
doi: 10.1016/j.urology.2023.09.002
pubmed: 37716456
Lerner LB, McVary KT, Barry MJ et al (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-surgical evaluation and treatment. J Urol 206:818–826. https://doi.org/10.1097/JU.0000000000002184
doi: 10.1097/JU.0000000000002184
pubmed: 34384236
Kim M, Piao S, Lee H-E et al (2015) Efficacy and safety of holmium laser enucleation of the prostate for extremely large prostatic adenoma in patients with benign prostatic hyperplasia. Korean J Urol 56:218–226. https://doi.org/10.4111/kju.2015.56.3.218
doi: 10.4111/kju.2015.56.3.218
pubmed: 25763126
pmcid: 4355433